Literature DB >> 3822958

Patient noncompliance and overcompliance. Behavior patterns underlying a patient's failure to 'follow doctor's orders'.

R A Boza, F Milanes, V Slater, L Garrigo, C E Rivera.   

Abstract

The vicissitudes of medical treatment are affected in large part by patient compliance. Noncompliance can be caused by a variety of psychological, somatic, and socioeconomic factors. Overcompliance would seem on the surface to be less of a problem, but it too can have serious consequences in terms of treatment success. Several psychological factors account for overcompliance. The physician's best defenses against both noncompliance and overcompliance are to listen carefully to the patient for clues to one of these impending behaviors and to establish good rapport with the patient. An individualized approach is important, and in some cases participation in organized self-help groups is of benefit.

Entities:  

Mesh:

Year:  1987        PMID: 3822958     DOI: 10.1080/00325481.1987.11699750

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

Review 1.  A systems view of health care for the poor.

Authors:  N Prasad
Journal:  J Natl Med Assoc       Date:  1989-02       Impact factor: 1.798

2.  Management of a locally advanced rectal cancer in a patient who declined surgery.

Authors:  Raafat Alameddine; David Wehbe; Martin Weiser; Neil Segal; Karyn Goodman; Ali Shamseddine; Celina Ang; Ali Haydar; Mustafa Sidani; Fady Geara; Mohamed Naghy; Eileen M O'Reilly; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2012-11

3.  Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

Authors:  Sven Simons; Susanne Ringsdorf; Michael Braun; Ulrich J Mey; Peter F Schwindt; Yon D Ko; Ingo Schmidt-Wolf; Walther Kuhn; Ulrich Jaehde
Journal:  Support Care Cancer       Date:  2010-06-16       Impact factor: 3.603

4.  Detecting participant noncompliance across multiple time points by modeling a longitudinal biomarker.

Authors:  Ross L Peterson; Joseph S Koopmeiners; Tracy T Smith; Sharon E Murphy; Eric C Donny; David M Vock
Journal:  Clin Trials       Date:  2020-09-14       Impact factor: 2.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.